Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas.
Amgen stock last closed at $311.41, up 0.96% from the previous day, and has increased 33.35% in one year. It has overperformed other stocks in the Drug Manufacturers - General industry by 0.18 percentage points. Amgen stock is currently +47.09% from its 52-week low of $211.71, and -5.55% from its 52-week high of $329.72.
At the moment, there are 536.43M shares of AMGN outstanding. The market cap of AMGN is $167.05B. In the past 24 hours, 1.63M AMGN shares were traded.
How to Buy Amgen Stock
Wondering how to invest in Amgen stock? Here's how.
Choose where to buy Amgen stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you decide where to buy Amgen stock.
Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Fund your brokerage account: Choose your method of payment and add your info.
Research Amgen stock: The Amgen ticker symbol is AMGN. Is Amgen stock a good investment? Should you buy shares of AMGN? How do AMGN's underlying business fundamentals look? Do top analysts think Amgen is a good buy? Why has AMGN's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if AMGN is a good stock to buy).
Execute your AMGN purchase: Decide if you will purchase AMGN shares at the current market price or use a limit order to purchase AMGN stock at a given price.
Get updates on your AMGN position: Create a watchlist to keep track of your new investment in Amgen shares.
Step 1: Choose where to buy Amgen stock
You will need an online brokerage account to access the NASDAQ market and buy AMGN shares.
A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to global markets: From Tech to Real Estate, New York to London — you can fill your portfolio with stocks from the world's leading stock exchanges.
Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've selected the right brokerage, you need to fill out some personal information so you can invest in AMGN today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Amgen stock
After you have decided on the best place to buy Amgen stock, it's critical to analyze their stock prior to buying, so you can wrap your head around the risk as well as the opportunity.
Amgen Metrics
AMGN Price
$311.41
1w %
3.7%
1y %
33.35%
5y %
85.57%
P/E
44.23x
P/B
33.26x
P/S
5.65x
PEG
1.01x
Revenue
$29.53B
Earnings
$3.76B
Fore. Rev. Growth
5.51%
Fore. Earn. Growth
43.72%
Market Cap
$167.05B
Next Earnings
N/A
Next Dividend
Jun 7, 2024
AMGN Zen Score
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis in less time.
There are more short-term assets than short-term liabilities on the AMGN balance sheet.
Negative Health Checks:
AMGN has a relatively high debt to equity ratio of 17.52.
There are more long-term liabilities than short-term assets on the AMGN balance sheet.
AMGN earnings of $7.50B is not enough to cover its interest payments.
AMGN's operating cash flow of $8.10B allows it to safely service it's debt of $64.02B.
Total AMGN debt is higher than 5 years ago, relative to shareholder equity.
AMGN profit margin has gone down from 30.2% to 12.7% in the past year.
Do analysts think it's a good time to buy AMGN stock
Out of 11 sell side analysts who give ratings on AMGN, the consensus analyst rating on Amgen is a Buy
It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.
Latest AMGN Analyst Upgrades/Downgrades
Carter Gould, a top 20% analyst from Barclays upgrades AMGN to a hold rating and raises their AMGN price target from $230.00 to $300.00, on May 3, 2024.
Yaron Werber, a bottom 4% analyst from TD Cowen maintains AMGN with a strong buy rating and lowers their AMGN price target from $370.00 to $360.00, on Apr 17, 2024.
Robyn Karnauskas, a bottom 7% analyst from Truist Securities reiterates AMGN with a strong buy rating and maintains their AMGN price target from $320.00 to $320.00, on Apr 12, 2024.
Salveen Richter, a top 28% analyst from Goldman Sachs maintains AMGN with a strong buy rating and raises their AMGN price target from $313.00 to $350.00, on Feb 8, 2024.
Jay Olson, a top 3% analyst from Oppenheimer reiterates AMGN with a buy rating and maintains their AMGN price target from $350.00 to $350.00, on Feb 1, 2024.
You can dig deeper into what analysts are projecting on the Amgen stock forecast page.
AMGN Momentum
SMA10
301.7
SMA20
286.05
SMA50
278.74
SMA100
288.02
SMA200
276.72
MACD
10.06
MACD Signal
6.67
MACD Histogram
3.39
RSI
68.93
Stochastic %K
77.85
Stochastic %D
78.44
StochRSI %K
69.47
StochRSI %D
72.38
AMGN Growth Numbers
Last year, AMGN earnings were $3.76B. Over the last five year, AMGN's earnings have grown by -11% per year. This was slower than the Drug Manufacturers - General industry average of 0.51%.
Last year, AMGN revenue was $29.53B. During the past 5 year, AMGN's revenue has grown by 4.45% per year. This was slower than the Drug Manufacturers - General industry average of 7.29%.
Amgen pays a dividend of 2.77%, compared to the Drug Manufacturers - General industry's average dividend yield of 3.54%. If you owned $1,000 of AMGN stock, you would have been paid $27.74 in the past year.
Amgen dividend payments have consistently grown over the past decade and have remained stable.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your AMGN purchase
There are two primary order types:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are usually the best for newer investors.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at an exact dollar amount, use a limit order.
Click the Open Trade button and your broker will execute the order.
If you want additional assistance investing in stocks on eToro, watch the how to video below:
As of May 14, 2024, it costs $311.41 to buy one share of Amgen stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.321 shares of AMGN.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.